Related websites>
-
Yang Sheng meets with associate commissioner for global policy and strategy of US FDA
On Jan 27, Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA) of China, met with a visiting delegation led by Mark Abdoo, associate commissioner for global regulatory operations and policy of the US Food and Drug Administration (FDA).
-
China revises drug administration regulations to spur innovation, tighten oversight
China has revised regulations concerning drug administration in a bid to promote drug innovation, strengthen management of online sales of medicines and reinforce drug safety supervision.
-
NMPA to enhance drug regulation under revised rules — committed to a people-centered healthy policy and strengthen high-effect regulation
The revised Regulation aims to further encourage drug research and innovation, strengthen the whole life-cycle control of drugs and provide a solid legal guarantee for high-level drug safety and the high-quality development of the pharmaceutical industry.
- Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
- Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
- Announcement of the National Medical Products Administration on the Release of the Good Manufacturing Practice for Medical Devices ([2025] No. 107)
- Policy Interpretation of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers
- Announcement of the National Medical Products Administration on Issuing the Administrative Provisions on Inspection and Export Certificate for Pharmaceutical Products Exported by Pharmaceutical Manufacturers([2025] No. 113)
- Revision and Release of the Good Manufacturing Practice for Medical Devices
